Skip to main content
Erschienen in: Journal of Cancer Education 3/2018

21.11.2016

Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States

verfasst von: Adil S. Akthar, Christopher D. Hellekson, Sabha Ganai, Olwen M. Hahn, Ronald J. Maggiore, Ezra E. Cohen, Mitchell C. Posner, Steven J. Chmura, Andrew R. Howard, Daniel W. Golden

Erschienen in: Journal of Cancer Education | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Oncologists must have a strong understanding of collaborating specialties in order to deliver optimal cancer care. The objective of this study was to quantify current interdisciplinary oncology education among oncology training programs across the USA, identify effective teaching modalities, and assess communication skills training. Web-based surveys were sent to oncology trainees and program directors (PDs) across the USA on April 1, 2013 and October 8, 2013, respectively. Question responses were Yes/No, five-point Likert scales (1 = not at all, 2 = somewhat, 3 = moderately, 4 = quite, 5 = extremely), or free response. Respondents included the following (trainees/PDs): 254/55 medical oncology, 160/42 surgical oncology, 102/24 radiation oncology, and 41/20 hospice and palliative medicine (HPM). Trainees consistently reported lower rates of interdisciplinary education for each specialty compared with PDs as follows: medical oncology 57 vs. 77% (p < 0.01), surgical oncology 30 vs. 44% (p < 0.01), radiation oncology 70 vs. 89% (p < 0.01), geriatric oncology 19 vs. 30% (p < 0.01), and HPM 55 vs. 74% (p < 0.01). The predominant teaching method used (lectures vs. rotations vs. tumor board attendance vs. workshop vs. other) varied according to which discipline was being taught. The usefulness of each teaching method was rated statistically different by trainees for learning about select disciplines. Furthermore, statistically significant differences were found between PDs and trainees for the perceived usefulness of several teaching modalities. This study highlights a deficiency of interdisciplinary education among oncology training programs in the USA. Efforts to increase interdisciplinary education opportunities during training may ultimately translate into improved collaboration and quality of cancer care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat IOM (Institute of Medicine) (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. The National Academies Press, Washington DC IOM (Institute of Medicine) (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. The National Academies Press, Washington DC
3.
Zurück zum Zitat Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. doi:10.1016/j.jbi.2008.08.010 CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. doi:10.​1016/​j.​jbi.​2008.​08.​010 CrossRefPubMed
4.
Zurück zum Zitat Rowley BD (1988) AMA—Fellowship and Residency Electronic Interactive Database Access (AMAFREIDA): a computerized residency selection tool. JAMA 260(8):1059CrossRefPubMed Rowley BD (1988) AMA—Fellowship and Residency Electronic Interactive Database Access (AMAFREIDA): a computerized residency selection tool. JAMA 260(8):1059CrossRefPubMed
5.
Zurück zum Zitat Naeim A, Hurria A, Rao A, Cohen H, Heflin M, Seo P (2010) The need for an aging and cancer curriculum for hematology/oncology trainees. Journal of Geriatric Oncology 1(2):109–113CrossRef Naeim A, Hurria A, Rao A, Cohen H, Heflin M, Seo P (2010) The need for an aging and cancer curriculum for hematology/oncology trainees. Journal of Geriatric Oncology 1(2):109–113CrossRef
6.
Zurück zum Zitat Schneider EL, Guralnik JM (1990) The aging of America. Impact on health care costs. JAMA 263(17):2335–2340CrossRefPubMed Schneider EL, Guralnik JM (1990) The aging of America. Impact on health care costs. JAMA 263(17):2335–2340CrossRefPubMed
8.
Zurück zum Zitat Back AL, Arnold RM, Baile WF, Fryer-Edwards KA, Alexander SC, Barley GE, Gooley TA, Tulsky JA (2007) Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 167(5):453–460. doi:10.1001/archinte.167.5.453 CrossRefPubMed Back AL, Arnold RM, Baile WF, Fryer-Edwards KA, Alexander SC, Barley GE, Gooley TA, Tulsky JA (2007) Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med 167(5):453–460. doi:10.​1001/​archinte.​167.​5.​453 CrossRefPubMed
Metadaten
Titel
Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States
verfasst von
Adil S. Akthar
Christopher D. Hellekson
Sabha Ganai
Olwen M. Hahn
Ronald J. Maggiore
Ezra E. Cohen
Mitchell C. Posner
Steven J. Chmura
Andrew R. Howard
Daniel W. Golden
Publikationsdatum
21.11.2016
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 3/2018
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-016-1139-6

Weitere Artikel der Ausgabe 3/2018

Journal of Cancer Education 3/2018 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.